Literature DB >> 4131694

Fine structure and morphogenesis of spironolactone bodies in the zona glomerulosa of the human adrenal cortex.

K Kovacs, E Horvath, W Singer.   

Abstract

Numerous spironolactone bodies have been detected in the zona glomerulosa cells of the adrenal cortex of a 36-year-old spironolactone-treated woman whose non-tumorous right adrenal gland was removed surgically because of primary hyperaldosteronism. Electron microscopy revealed spherical laminated whorls which consisted of a central core composed of an amorphous electron-dense material surrounded by numerous smooth-walled concentric membranes. Continuous with and deriving from the endoplasmic reticulum, they were present in viable cells and were not associated with ultrastructural features indicating cellular injury. Cytoplasmic inclusions similar to spironolactone bodies can be detected in other organs after the administration of various compounds. Thus, they can be regarded as neither specific to spironolactone treatment nor exclusively inducible in the zona glomerulosa of the adrenal cortex.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4131694      PMCID: PMC477936          DOI: 10.1136/jcp.26.12.949

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  17 in total

1.  Effect of cycloheximide on the rat adrenal cortex: a light and electron microscopic study.

Authors:  K Kovacs; J D Khandekar; S Szabó; B D Garg; B Tuchweber
Journal:  Rev Can Biol       Date:  1972-06

2.  Drug-induced and naturally occurring myeloid bodies.

Authors:  Z Hruban; A Slesers; E Hopkins
Journal:  Lab Invest       Date:  1972-07       Impact factor: 5.662

3.  Adrenocortical lipid hyperplasia induced in rats by aniline. A histologic and electron microscopic study.

Authors:  K Kovacs; J A Blascheck; E Yeghiayan; S Hatakeyama; C Gardell
Journal:  Am J Pathol       Date:  1971-01       Impact factor: 4.307

4.  Effect of spironolactone on the zona. Light and electron microscopy.

Authors:  E H Jenis; R W Hertzog
Journal:  Arch Pathol       Date:  1969-11

5.  [Lamellar formation in the adrenal cortex of the rat].

Authors:  K Kovacs; J D Khandekar; S Szabo; B D Garg; C Gardell; B Tuchweber
Journal:  Arch Biol (Liege)       Date:  1971

6.  Experimental production of so-called spironolactone bodies.

Authors:  E R Fisher; B Horvat
Journal:  Arch Pathol       Date:  1971-05

7.  L [Lipoid transformation of adrenocortical mitochondria in the rat after aminoglutethimide (Elipten Ciba)].

Authors:  J Marek; W Thoenes; K Motlík
Journal:  Virchows Arch B Cell Pathol       Date:  1970

8.  Observations on the fine structure of the adrenal cortex of man.

Authors:  J A Long; A L Jones
Journal:  Lab Invest       Date:  1967-10       Impact factor: 5.662

9.  Spironolactone (aldactone) bodies: concentric lamellar formations in the adrenal cortices of patients treated with spironolactone.

Authors:  D A Davis; N M Medline
Journal:  Am J Clin Pathol       Date:  1970-07       Impact factor: 2.493

10.  Activation of aldosterone secretion in primary aldosteronism.

Authors:  R F Spark; S L Dale; P C Kahn; J C Melby
Journal:  J Clin Invest       Date:  1969-01       Impact factor: 14.808

View more
  7 in total

1.  [Effects of drugs on the adrenal cortex and its tumors].

Authors:  W Saeger; M Fassnacht
Journal:  Pathologe       Date:  2006-02       Impact factor: 1.011

2.  Spironolactone bodies in aldosteronomas and in the attached adrenals. Enzyme histochemical study of 19 cases of primary aldosteronism and a case of aldosteronism due to bilateral diffuse hyperplasia of the zona glomerulosa.

Authors:  M Aiba; H Suzuki; K Kageyama; M Murai; H Tazaki; O Abe; T Saruta
Journal:  Am J Pathol       Date:  1981-06       Impact factor: 4.307

3.  Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia.

Authors:  M Fischer; W Vetter; B Winterg; W Zidek; H Vetter
Journal:  Eur J Nucl Med       Date:  1982

4.  Adrenal adenomata causing primary aldosteronism. An ultrastructural study of twenty five cases.

Authors:  K I Kano; S Sato; H Hama
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1979

5.  Ultrastructural studies of adrenal adenoma causing primary aldosteronism.

Authors:  H Kuramoto; J Kumazawa
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

6.  Mineralocorticoid Receptor Antagonists Eplerenone and Spironolactone Modify Adrenal Cortex Morphology and Physiology.

Authors:  Sofia S Pereira; Liliana Carvalho; Madalena M Costa; Armindo Melo; Isabel M P L V O Ferreira; Celso E Gomez-Sanchez; Mariana P Monteiro; Gavin Vinson; Duarte Pignatelli
Journal:  Biomedicines       Date:  2021-04-20

7.  Adrenal gland inclusions in patients treated with aldosterone antagonists (Spironolactone/Eplerenone): incidence, morphology, and ultrastructural findings.

Authors:  Kishan A Patel; Edward P Calomeni; Tibor Nadasdy; Debra L Zynger
Journal:  Diagn Pathol       Date:  2014-08-09       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.